Festive-season malaria warning for South African travellers

With the summer holiday rush under way and travel into South Africa’s bush and border regions increasing, health authorities are again flagging a heightened risk of malaria between September and May and urging travellers to plan ahead.

Peak season aligns with holiday travel

Malaria transmission in South Africa is highly seasonal, with cases rising from spring and typically peaking in the hot, wet months of January and February before tapering off towards May. Publicly available surveillance data from the National Department of Health and the National Institute for Communicable Diseases show that this period aligns closely with the festive-season break, when many residents and international visitors head for game reserves and low-lying river valleys.

Government guidance identifies September to May as the malaria season, when environmental conditions favour breeding of Anopheles mosquitoes, the insects that transmit the parasite. The highest transmission occurs in the low-altitude areas of Limpopo, Mpumalanga and northern KwaZulu-Natal, particularly along the borders with Mozambique, Eswatini, Zimbabwe and Botswana.

Although South Africa has made major progress in reducing malaria over the past two decades, it remains a serious concern. A 2024 national vector-control report cited nearly 9 800 malaria cases and just over 100 deaths recorded in 2023, underscoring that the disease is still present and potentially fatal, especially for people with no prior exposure.

Travel medicine services and international advisory platforms emphasise that festive-season visitors to Kruger National Park and surrounding reserves, as well as to certain parts of Limpopo and KwaZulu-Natal, face a measurable risk and should treat malaria prevention as a core part of trip planning.

Where the risk is highest for holidaymakers

According to South African government information, malaria is endemic in defined regions of just three provinces: north-eastern KwaZulu-Natal, parts of Mpumalanga and Limpopo. Transmission is concentrated at lower altitudes, generally below 1 000 metres above sea level, and is most intense in districts abutting neighbouring endemic countries.

International travel health advisories specify that the low-altitude areas of Mpumalanga and Limpopo, including Kruger National Park and many private reserves on its borders, carry enough seasonal risk between September and May to justify both bite avoidance and, for many travellers, chemoprophylaxis. In parts of far north-eastern KwaZulu-Natal and selected areas of Limpopo and Mpumalanga, the risk is assessed as low to very low, but still present in the warm, rainy months.

By contrast, the rest of South Africa, including major cities such as Johannesburg, Cape Town, Durban (outside the far north of the province) and most inland and coastal holiday regions, is not regarded as having local malaria transmission. Travellers who confine their trips to these non-endemic destinations do not require malaria tablets, although they may still choose general mosquito precautions for comfort and to protect against other biting insects.

For South Africans crossing borders during the festive season, the picture changes significantly. Health advisories stress that a number of neighbouring and regional destinations, including parts of Mozambique, Zimbabwe, Zambia, Malawi and Angola, have year-round and often higher malaria transmission than South Africa’s endemic zones, with preventive medication strongly recommended for many itineraries.

Updated guidance on malaria tablets and who needs them

World Health Organization fact sheets and South African clinical guidance agree that a combination of mosquito avoidance measures and appropriate chemoprophylaxis offers the most effective protection for travellers to malaria areas. However, not every itinerary requires the same approach, and decisions should be tailored to the route, season, length of stay and individual health profile.

National guidance issued in January 2024 confirmed that doxycycline is now included in South Africa’s public-sector Standard Treatment Guidelines and Essential Medicines List as an option for malaria chemoprophylaxis for eligible travellers aged eight years and older visiting moderate or high-risk endemic areas between September and May. The circular advises that prophylaxis begins two days before entering a malaria zone and continues for four weeks after leaving, and that it must always be combined with non-drug measures such as insect repellent and protective clothing.

Travel health resources commonly list atovaquone/proguanil, doxycycline and mefloquine as standard antimalarial options for many Southern African destinations, subject to individual contraindications and local resistance patterns. Each medicine has a specific dosing schedule and potential side effects profile, meaning that advance consultation with a healthcare professional is recommended, particularly for pregnant travellers, young children and people with chronic medical conditions.

South African clinical documents also caution that pregnant women, children younger than eight years and immunocompromised individuals are more vulnerable to severe malaria and are generally advised to avoid unnecessary travel to malaria-endemic areas. Where travel during the festive season cannot be postponed, specialist medical advice on the safest prevention plan is considered essential.

Bite prevention remains the first line of defence

Government advisories stress that even the best antimalarial tablets are not fully protective and that avoiding mosquito bites is crucial. The main malaria vectors in South Africa typically feed between dusk and dawn, a time when many holidaymakers are on game drives, at outdoor braais or relaxing on lodge decks, which raises the likelihood of exposure if precautions are not taken.

Practical measures promoted in official guidance include using insect repellents on exposed skin that contain at least a moderate concentration of active ingredients such as DEET, closing doors and windows or using intact screens at night, and sleeping under mosquito nets where available. Air conditioning and fans can further reduce mosquito activity indoors.

Travellers are also encouraged to wear long-sleeved, light-coloured shirts, long trousers and socks in the evenings and early mornings in endemic areas, and to treat or spray accommodation with approved insecticides where appropriate. Lodges and camps in higher-risk zones commonly combine these steps with regional vector-control programmes, such as indoor residual spraying, but individual behaviour remains a decisive factor.

For families and groups moving between non-endemic cities and endemic parks over the festive break, experts highlight the importance of maintaining bite precautions consistently from the first evening in a risk area until several days after leaving, to cover the typical lifespan of potentially infectious mosquitoes.

Know the symptoms and act fast after your trip

South African malaria information resources emphasise that early recognition and urgent medical care can be lifesaving. Symptoms often develop 10 to 14 days after an infectious mosquito bite but may appear later, especially in those taking chemoprophylaxis, so the risk window extends well beyond the holiday itself.

Typical early features include fever, chills, sweating, headache, fatigue, muscle and joint pains, abdominal discomfort, nausea, vomiting or diarrhoea. These may be mistaken for influenza or a gastrointestinal infection, particularly during the festive season when other viral illnesses circulate, which can delay diagnosis.

National guidance urges anyone who develops flu-like symptoms within several weeks of visiting a malaria area, and up to about six months afterwards, to inform healthcare providers of their travel history and request assessment for malaria. Rapid diagnostic tests and blood smears are widely used in endemic districts and major urban centres, and treatment is generally effective when started promptly.

Travel health agencies advise that even travellers who took malaria tablets should not ignore symptoms, as no prophylactic regimen is completely protective. For those planning remote festive-season trips with limited access to medical facilities, some international guidelines discuss the possibility of standby emergency treatment, but this requires careful pre-travel consultation to ensure appropriate use.